1Life dips after WSJ says FTC considering antitrust suit against Amazon

Shares of 1Life Healthcare (ONEM) are down 41c or about 3%, to $15.21 in morning trading after The Wall Street Journal’s Dana Mattioli and Brent Kendall reported, citing sources, that The Federal Trade Commission is considering challenges to an array of practices by Amazon (AMZN) that it considers anticompetitive. Which aspects of Amazon’s business the FTC would target in a potential Amazon lawsuit couldn’t be learned, the report said. Amazon has entered into an agreement to acquire 1Life, which operates a membership-based primary care platform under the One Medical brand.